EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/06/20
EyePoint Pharmaceuticals Provides COVID-19 Pandemic Business Operations UpdateGlobeNewsWire • 04/01/20
EyePoint Pharmaceuticals' (EYPT) CEO Nancy Lurker on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/05/20
EyePoint Pharmaceuticals Announces Positive Topline 36-month Follow-up Data for Second Phase 3 Study of YUTIQ®GlobeNewsWire • 03/02/20
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common StockGlobeNewsWire • 02/21/20
EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein OcclusionGlobeNewsWire • 02/03/20
EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize DEXYCU® for Post-operative Inflammation in Mainland China, Hong Kong, Macau and TaiwanGlobeNewsWire • 01/27/20
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/08/19
EyePoint Pharmaceuticals Announces Addition of DEXYCU® and YUTIQ® to Department of Veteran Affairs Federal Supply ScheduleGlobeNewsWire • 11/04/19
Will EyePoint Pharmaceuticals (EYPT) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 10/31/19
EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in EffectGlobeNewsWire • 10/02/19
EyePoint Pharmaceuticals Announces YUTIQ® Presentations at the American Academy of Ophthalmology 2019 Annual MeetingGlobeNewsWire • 09/27/19
EyePoint Pharmaceuticals to Present at the 2019 Cantor Global Healthcare ConferenceGlobeNewsWire • 09/26/19
Why Investors Have Underestimated EyePoint's Dexycu And Yutiq Growth Potential Since LaunchSeeking Alpha • 09/24/19
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 52nd Annual Retina Society Scientific MeetingGlobeNewsWire • 09/09/19